Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1

Abstract

E-cadherin is a key cell adhesion molecule implicated as a tumor suppressor, which is frequently altered in hepatocellular carcinoma, especially in hepatitis B virus (HBV)-related tumors. Here, we report that HBV X protein (HBx) represses E-cadherin expression at the transcription level. Based on the differential effects of HBx natural variants, we determined that Lys-130 in the transactivation domain of HBx is critical for the E-cadherin repression. The repression effect of HBx was abolished after treatment with DNA methyltransferase inhibitor, 5′-Aza-2′dC. In addition, methylation-specific PCR analysis revealed that the CpG island 1 of E-cadherin promoter is hypermethylated by HBx. Furthermore, HBx induces DNA methyltransferase 1 expression by stimulating its transcription. Therefore, we conclude that HBx represses E-cadherin expression by inducing methylation-mediated promoter inactivation. The reduced E-cadherin expression results in dramatic morphological changes of the HBx-expressing cells. In addition, HBx-expressing cells aggregate poorly in suspension culture, reflecting their altered intercellular interactions. The biological significance was further demonstrated by the increased collagen invasion ability of HBx-expressing cells. Therefore, the present study suggests that HBx plays a role during hepatocellular carcinogenesis by favoring cell detachment from the surrounding cells and migration outside of the primary tumor site.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Abbreviations

HBV:

hepatitis B virus

HBx:

HBV X protein

DNMT:

DNA methylatransferase

GAPDH:

glyceraldehyde 3-phosphate dehydrogenase

HBSS:

Hank's balanced salt solution

HCC:

hepatocellular carcinoma

MMP:

matrix metalloproteinase

MSP:

methylation-specific PCR

SDS:

sodium dodecyl sulfate

References

  • Anzola M . (2004). J. Viral. Hepat., 11, 383–393.

  • Baptista M, Kramvis A and Kew MC . (1999). Hepatology, 29, 946–953.

  • Benn J, Su F, Doria M and Schneider RJ . (1996). J. Virol., 70, 4978–4985.

  • Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F and Cornelisse C . (1996). Oncogene, 13, 1919–1925.

  • Bigey P, Ramchandani S, Theberge J, Araujo FD and Szyf M . (2000). Gene, 242, 407–418.

  • Block TM, Mehta AS, Fimmel CJ and Jordan R . (2003). Oncogene, 22, 5093–5107.

  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA . (2000). Nat. Cell Biol., 2, 76–83.

  • Chan CF, Yau TO, Jin DY, Wong CM, Fan ST and Ng IO . (2004). Clin. Cancer Res., 10, 4140–4149.

  • Chung TW, Lee YC and Kim CH . (2004). FASEB J., 18, 1123–1125.

  • Diao J, Garces R and Richardson CD . (2001). Cytokine Growth Factor Rev., 12, 189–205.

  • Feitelson MA and Duan LX . (1997). Am. J. Pathol., 150, 1141–1157.

  • Foty RA and Steinberg MS . (2004). Int. J. Dev. Biol., 48, 397–409.

  • Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W . (1991). J. Cell Biol., 113, 173–185.

  • Gorman CM, Merlino GT, Willingham MC, Pastan I and Howard BH . (1982). Proc. Natl. Acad. Sci. USA, 79, 6777–6781.

  • Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9821–9826.

  • Hirohashi S . (1998). Am. J. Pathol., 153, 333–339.

  • Hirohashi S and Kanai Y . (2003). Cancer Sci., 94, 575–581.

  • Hsia CC, Yuwen H and Tabor E . (1996). Lancet, 348, 625–626.

  • Jia L, Wang XW and Harris CC . (1999). Int. J. Cancer, 80, 875–879.

  • Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M and Hirohashi S . (1997). Int. J. Cancer, 71, 355–359.

  • Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N and Niitsu Y . (1995). Mol. Cell. Biol., 15, 1175–1181.

  • Kim CM, Koike K, Saito I, Miyamura T and Jay G . (1991). Nature, 351, 317–320.

  • Kwun HJ and Jang KL . (2004). Nucleic Acids Res., 32, 2202–2213.

  • Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M, Martinez-A C, Arroyo AG and Lopez-Cabrera M . (2002). J. Clin. Invest., 110, 1831–1838.

  • Lara-Pezzi E, Majano PL, Yanez-Mo M, Gomez-Gonzalo M, Carretero M, Moreno-Otero R, Sanchez-Madrid F and Lopez-Cabrera M . (2001a). J. Hepatol., 34, 409–415.

  • Lara-Pezzi E, Roche S, Andrisani OM, Sanchez-Madrid F and Lopez-Cabrera M . (2001b). Oncogene, 20, 3323–3331.

  • Lara-Pezzi E, Serrador JM, Montoya MC, Zamora D, Yanez-Mo M, Carretero M, Furthmayr H, Sanxhez-Madrid F and Lopez-Cabrera M . (2001c). Hepatology, 33, 1270–1281.

  • Lee CW, Sorensen TS, Shikama N and La Thangue NB . (1998). Oncogene, 16, 2695–2710.

  • Matsumura T, Makino R and Mitamura K . (2001). Clin. Cancer Res., 7, 594–599.

  • Melki JR, Vincent PC, Brown RD and Clark SJ . (2000). Blood, 95, 3208–3213.

  • Miyasaka M . (1995). Clin. Orthop., 312, 10–18.

  • Nabi IR . (1999). J. Cell Sci., 112, 1803–1811.

  • Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB and Schuebel KE . (2000). Nature, 404, 1003–1007.

  • Sanders DS, Blessing K, Hassan GA, Bruton R, Marsden JR and Jankowski J . (1999). Mol. Pathol., 52, 151–157.

  • Santi D, Norment A and Garrett CE . (1984). Proc. Natl. Acad. Sci. USA, 81, 6996–6997.

  • Shih WL, Kuo ML, Chuang SE, Cheng AL and Doong SL . (2000). J. Biol. Chem., 275, 25858–25864.

  • Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, Batchelor W, Regele H, Sega W, Boesmueller H, Krausz T and Pignatelli M . (1998). J. Pathol., 186, 350–355.

  • Takahashi K, Akahane Y, Hino K, Ohta Y and Mishiro S . (1998). Arch. Virol., 143, 2313–2326.

  • Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P and Buendia MA . (1997). Oncogene, 14, 395–404.

  • Tsai CN, Tsai CL, Tse KP, Chang HY and Chang YS . (2002). Proc. Natl. Acad. Sci. USA, 99, 10084–10089.

  • Venard V, Corsaro D, Kajzer C, Bronowicki JP and Le Faou A . (2000). J. Med. Virol., 62, 177–184.

  • Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR and Harris CC . (1994). Proc. Natl. Acad. Sci. USA, 91, 2230–2234.

  • Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH and Harris CC . (1995). Cancer Res., 55, 6012–6016.

  • Watabe M, Nagafuchi A, Tsukita S and Takeichi M . (1994). J. Cell Biol., 127, 247–256.

  • Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P and Buendia MA . (2002). Hepatology, 36, 692–701.

  • Wheelock MJ and Johnson KR . (2003). Annu. Rev. Cell Dev. Biol., 19, 207–235.

  • Yoo YG, Oh SH, Park ES, Cho H, Lee N, Park H, Kim DK, Yu DY, Seong JK and Lee MO . (2003). J. Biol. Chem., 278, 39076–39084.

  • Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T and Hirohashi S . (1995). Proc. Natl. Acad. Sci. USA, 92, 7416–9419.

Download references

Acknowledgements

This work was supported by a grant from Pusan National University. HJK was supported by a postdoctoral training fellowship from Pusan National University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyung Lib Jang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JO., Kwun, H., Jung, J. et al. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24, 6617–6625 (2005). https://doi.org/10.1038/sj.onc.1208827

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208827

Keywords

This article is cited by

Search

Quick links